Cargando…

PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK

Detalles Bibliográficos
Autores principales:	Harrison, Ewan M., Ba, Xiaoliang, Blane, Beth, Ellington, Matthew J., Loeffler, Anette, Hill, Robert L. R., Holmes, Mark A., Peacock, Sharon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681373/ https://www.ncbi.nlm.nih.gov/pubmed/26462986 http://dx.doi.org/10.1093/jac/dkv317

Ejemplares similares

1453. PBP2, PBP2a and PBP4 Clone-specific Polymorphisms are not Associated to Ceftaroline (CPT) Susceptibility in Chilean Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Spencer, Maria de los Angeles, et al.
Publicado: (2020)

Local Persistence of Novel MRSA Lineage after Hospital Ward Outbreak, Cambridge, UK, 2011–2013
por: Toleman, Michelle S., et al.
Publicado: (2016)

Incidence and Characterisation of Methicillin-Resistant Staphylococcus aureus (MRSA) from Nasal Colonisation in Participants Attending a Cattle Veterinary Conference in the UK
por: Paterson, Gavin K., et al.
Publicado: (2013)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA
por: Varela, Maria Celeste, et al.
Publicado: (2020)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

Rapid sequencing of MRSA direct from clinical plates in a routine microbiology laboratory
por: Blane, Beth, et al.
Publicado: (2019)

1367. Reduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s HospitalReduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s Hospital
por: Sommer, Lauren, et al.
Publicado: (2020)

Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms
por: Lázaro-Díez, María, et al.
Publicado: (2016)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

Defining metrics for whole-genome sequence analysis of MRSA in clinical practice
por: Raven, Kathy E., et al.
Publicado: (2020)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Prospective genomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) associated with bloodstream infection, England, 1 October 2012 to 30 September 2013
por: Toleman, Michelle S, et al.
Publicado: (2019)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

Validation of self-administered nasal swabs and postage for the isolation of Staphylococcus aureus
por: Harrison, Ewan M., et al.
Publicado: (2016)

A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
por: Lounsbury, Nicole, et al.
Publicado: (2019)

Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a
por: Dai, Jie, et al.
Publicado: (2023)

Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA carriage, infection and transmission
por: Paterson, Gavin K., et al.
Publicado: (2015)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes
por: Kumar, Narender, et al.
Publicado: (2020)

Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
por: Faris, Janie, et al.
Publicado: (2015)

Prevalence and characterization of mecC MRSA in bovine bulk tank milk in Great Britain, 2017–18
por: Cui, Cheng, et al.
Publicado: (2021)

Flavonoids as Potential anti-MRSA Agents through Modulation of PBP2a: A Computational and Experimental Study
por: Alhadrami, Hani A., et al.
Publicado: (2020)

Nasal carriage of Staphylococcus pseudintermedius in patients with granulomatosis with polyangiitis
por: Kronbichler, Andreas, et al.
Publicado: (2019)

Targeting of PBP1 by β-lactams Determines recA/SOS Response Activation in Heterogeneous MRSA Clinical Strains
por: Plata, Konrad B., et al.
Publicado: (2013)

Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections
por: Saraiva, Felipe Betoni, et al.
Publicado: (2019)

A novel PBP3 substitution in Haemophilus influenzae confers reduced aminopenicillin susceptibility
por: Thegerström, John, et al.
Publicado: (2018)

Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals
por: Andrey, D. O., et al.
Publicado: (2016)

Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Dalbavancin Alone and in Combination with Ceftaroline against Methicillin-Resistant Strains (MRSA) of Staphylococcus aureus
por: Kebriaei, Razieh, et al.
Publicado: (2017)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

174. Impact of Ceftaroline Duration after Bacteremia Clearance When Used in Combination Therapy for Persistent or High-grade MRSA Bacteremia
por: Cabanilla, M Gabriela, et al.
Publicado: (2023)

Stable antibiotic resistance and rapid human adaptation in livestock-associated MRSA
por: Matuszewska, Marta, et al.
Publicado: (2022)

Resistance to β-Lactam Antibiotics Conferred by Point Mutations in Penicillin-Binding Proteins PBP3, PBP4 and PBP6 in Salmonella enterica
por: Sun, Song, et al.
Publicado: (2014)

Inhibitory Effect of Duabanga grandiflora on MRSA Biofilm Formation via Prevention of Cell-Surface Attachment and PBP2a Production
por: Santiago, Carolina, et al.
Publicado: (2015)

Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
por: Neil, Jason R., et al.
Publicado: (2021)

Large-Scale Evaluation of a Rapid Fully Automated Analysis Platform to Detect and Refute Outbreaks Based on MRSA Genome Comparisons
por: Raven, Kathy E., et al.
Publicado: (2022)

2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lld07b2ht16lb2onolipjgkcvp